Article Versions Notes

Demuth P, Thibol L, Lemsch A, Potlitz F, Schulig L, Grathwol C, Manolikakes G, Schade D, Roukos V, Link A, et al. Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors. Cancers. 2024; 16(20):3441. https://doi.org/10.3390/cancers16203441

Demuth, Philipp, Lea Thibol, Anna Lemsch, Felix Potlitz, Lukas Schulig, Christoph Grathwol, Georg Manolikakes, Dennis Schade, Vassilis Roukos, Andreas Link, and et al. 2024. "Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors" Cancers 16, no. 20: 3441. https://doi.org/10.3390/cancers16203441

Demuth, P., Thibol, L., Lemsch, A., Potlitz, F., Schulig, L., Grathwol, C., Manolikakes, G., Schade, D., Roukos, V., Link, A., & Fahrer, J. (2024). Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors. Cancers, 16(20), 3441. https://doi.org/10.3390/cancers16203441